RESP-FIT: Technology-Enhanced Self-Management in COPD
RESP-FIT
1 other identifier
interventional
34
1 country
1
Brief Summary
30 adults, aged 40 and older with mild to moderate COPD, will be recruited for this study. Participants must be willing to continually wear a FitBit activity monitor, have access to a smartphone or Wi-Fi/Data-enabled iPad, and be willing to complete respiratory muscle strength training exercises as well as reports on their smartphone at least 5 times per week for a 6-week period. Participants will be given a bluetooth inhaler device and a training app (RESP-FIT). This application will collect inhaler data and allows patients to self-report their daily symptoms. The goal of this study is to test whether use of the personalized inhaler device with the app strengthens lung function, promotes physical activity, and improves disease symptom self-management in persons with COPD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 18, 2018
CompletedFirst Submitted
Initial submission to the registry
June 26, 2018
CompletedFirst Posted
Study publicly available on registry
August 29, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 13, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 13, 2020
CompletedResults Posted
Study results publicly available
March 30, 2021
CompletedMarch 30, 2021
March 1, 2021
2 years
June 26, 2018
January 12, 2021
March 4, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Intervention Feasibility (Number of Participants Who Adhered to Treatment)
Feasibility of intervention was measured by the number of participants who adhered to treatment and completed the trial (from baseline to final visit follow-up). Treatment acceptability was measured by the Mobile Application Rating Scale. The Mobile Application Rating Scale asks the participant to report the appropriateness of the app for his/her target audience ranging from little or no (1) to very high level of the acceptability measure (5).
through study completion, average of 6 weeks
Secondary Outcomes (3)
Change in Self-efficacy
baseline, 6 weeks
Change in Fatigue
baseline, 6 weeks
Dyspnea
baseline, 6 weeks
Study Arms (2)
RESP-FIT Intervention
EXPERIMENTALIntervention: IMST/EMST Training (5 breaths, 5 times a day, 5 times a week) Fitbit activity monitoring Daily symptom and training log entered into mobile application (SAMS)
RESP-FIT Comparator
ACTIVE COMPARATORActive Comparator: Fitbit activity monitoring (Daily) Daily symptom and training log entered into mobile application (SAMS)
Interventions
Inspiratory and Expiratory muscle strength training 5 times a week, plus Fitbit activity monitoring (Daily) Daily symptom and training log entered into mobile application (SAMS)
Fitbit activity monitoring (Daily) Daily symptom and training log entered into mobile application (SAMS)
Eligibility Criteria
You may qualify if:
- years of age or older; and
- Able to read and write English; and
- Diagnosed with mild to moderate COPD (PFT values: FEV1/FVC \<0.7 and FEV1% predicted \< 50% - within the past 6 months); and
- Dyspnea score of greater than "2" on the Modified Medical Research Council (MMRC) questionnaire.
You may not qualify if:
- Pregnant female or less than 1 year post-partum; or
- Diagnosed cognitive deficit or observed lack of understanding during the informed consent process; or
- Mobility impairment; or
- Lack of 3g WiFi access in place of residence; or
- Unwillingness to wear physical activity tracker daily, follow protocol, and/ or attend study visits.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical University of South Carolinalead
- University of Floridacollaborator
Study Sites (1)
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Sarah Miller, PhD, RN
- Organization
- MUSC
Study Officials
- PRINCIPAL INVESTIGATOR
Sarah Miller, PhD, RN
Medical University of South Carolina
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 26, 2018
First Posted
August 29, 2018
Study Start
January 18, 2018
Primary Completion
January 13, 2020
Study Completion
January 13, 2020
Last Updated
March 30, 2021
Results First Posted
March 30, 2021
Record last verified: 2021-03